Vivonics, Inc. Licenses Groundbreaking Intra-Nasal Brain Cooling Technology to NeuroIntact, Inc.

 

FOR IMMEDIATE RELEASE

Bedford, MA / Baltimore, MD - [8-9-23] - Vivonics, Inc., a pioneering medical device technology development company based in Bedford, MA, and NeuroIntact, Inc., an early-stage start-up company developing products to improve management of brain health, are pleased to jointly announce the licensing of Vivonics’ patented intra-nasal brain cooling technology to NeuroIntact.   

Under this intellectual property agreement, Vivonics has granted NeuroIntact exclusive rights to develop, manufacture, and market products based on the revolutionary intra-nasal brain cooling technology. The cutting-edge device utilizing this technology, known as ICEPICC (Intra-nasal Cooling for Encephalopathy Prevention in Critical Care), has shown significant potential in reducing brain swelling and mitigating the effects of traumatic brain injury, stroke, and other brain illnesses or injuries.

Vivonics, founded in 2012, has worked since 2017 to create the innovative brain cooling technology that now holds the potential to revolutionize critical care. The company's efforts were bolstered by Phase I and II Small Business Innovation Research (SBIR) funding from the US Marine Corps, with the specific aim of improving treatment outcomes for combat casualties.

"We are thrilled to enter this relationship with NeuroIntact to bring our groundbreaking intra-nasal brain cooling technology one step closer to making a positive impact on patients' lives," said Gordon B. Hirschman, President and CEO of Vivonics, Inc. "The licensing agreement reflects our commitment to advancing medical technologies and ensuring that the benefits of our innovation reach the patients who need it the most."

NeuroIntact, founded by its President Bryan Nicholson, is a visionary start-up that aims to revolutionize the field of critical care with its focus on advancing the application of cutting-edge technologies. With the acquisition of Vivonics' intra-nasal brain cooling technology, NeuroIntact plans to undertake full product development, seek FDA clearance, and ultimately bring the ICEPICC device to market.

"NeuroIntact wants to thank the US Marine Corps and Vivonics for the opportunity to commercialize our first product. NeuroIntact, along with our partners, aims to ensure patients maintain brain function,” stated Bryan Nicholson, CEO of NeuroIntact, Inc. "Our team has experience in the Targeted Temperature Management (TTM) market, and we see a clear need for a deployable solution in minutes to cool the brain directly for neurological protection."

Focal brain cooling has emerged as a promising approach in the treatment of traumatic brain injuries, strokes, and other brain illnesses or injuries. By leveraging intra-nasal cooling, ICEPICC aims to provide an efficient and minimally invasive method to mitigate brain damage, leading to improved patient recovery and outcomes.

About Vivonics, Inc.

Vivonics, Inc. is a small medical device technology development company located in Bedford, MA, near Boston. Founded in 2012, Vivonics has created innovative medical technologies, some of which are already licensed to other companies for commercialization. Looking forward, Vivonics' mission is to improve human health, wellness, and performance in diverse and challenging environments by developing innovative, non-invasive physiological monitoring, diagnostic, and decision-support technologies.

About NeuroIntact, Inc.

NeuroIntact, Inc. is a dynamic start-up company headquartered in Baltimore, MD. Founded by visionary CEO Bryan Nicholson, NeuroIntact Inc. is a medical device development company focused on preserving the brain by maintaining neurological intactness. The licensing of Vivonics' intra-nasal brain cooling technology is a significant milestone in NeuroIntact's mission to preserve brain function of our patient population. 

For more information, please contact:

Vivonics, Inc. Address: 175 Great Road, Bedford, MA  01730.  Email:  info@vivonics.com   Phone:  781-373-1930

NeuroIntact, Inc. Address: 1100 Wicomico Street, Baltimore, MD 21230 Email: info@neurointact.com Phone: 717-576-8584

 

Vivonics to participate in “Precision in Medical Devices” Virtual Summit

PHOTO-2021-06-04-06-40-38.jpg

Vivonics has been invited to participate in a virtual summit titled “Precision in Medical Devices” being hosted by the Precision Evolution Global Precision on June 24, 2021. 

Vivonics will be represented by Lead Scientist & Director of Business Development Dr. Ryan Myers, who will be featured as a Keynote Speaker during the Medical Device Design & Development track and speak to non-dilutive government funding and how it provides small businesses a means and a reason to innovate! Dr. Myers has led and participated in a many research and commercial studies involving the development and testing of medical devices, biological equipment, biomaterials, flexible electronic fabrication, and wearable electronic systems, and has a proven track record of successfully soliciting non-dilutive government funding for these innovative biomedical approaches to complex problems.

Learn more at Info@Precision-Globe.com

Vivonics to participate in “Next Generation Sensor and Applications” at UMASS Lowell

Event Speakers.png

Vivonics has been invited to participate in a virtual seminar titled “Next Generation Sensor and Applications” being hosted by the UMass Lowell Innovation Hub on March 3, 2021.  The program will spotlight the work of UMASS and local industries on the growing role of sensors in the aviation, defense, environmental, health care and robotics. 

Vivonics will be represented by Biomedical Engineer Saukhyda Deshmukh, who received her Masters degree from UMASS Lowell and is involved in a collaborative research project between Vivonics and UMASS.

More information appears in this article in Lowell newspaper The Sun: https://www.lowellsun.com/2021/02/21/umass-lowell-to-showcase-the-future-of-sensor-technology/

Vivonics subsidiary, CranioSense wins the Johnson & Johnson Innovation Award at the 2020 M2D2 $200K Challenge!

“The Massachusetts Medical Device Development Center (M2D2) is a lifeline for the state’s smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the UMASS Lowell and the UMass Medical School campuses of the University of Massachusetts.”